Cardiovascular prevention with glucose-lowering drugs in type 2 diabetes: An evidence-based approach to the categories of primary and secondary prevention.
Edoardo MannucciGiovanni Antonio SilveriiPublished in: Diabetes, obesity & metabolism (2023)
The distinction between patients with ASCVD and those without ASCVD and MRF appears therefore justified by available evidence.